Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database

In this letter to the editor, we present results of claims data analysis. This claims data analysis supports a hypothesis that in patients with hereditary angioedema due to C1-esterase inhibitor (C1-INH) deficiency, the occurrence and/or symptomatology of coexisting autoimmune disease may be positiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Farkas, Henriette, Levy, Donald, Supina, Dylan, Berger, Melvin, Prusty, Subhransu, Fridman, Moshe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254637/
https://www.ncbi.nlm.nih.gov/pubmed/32514273
http://dx.doi.org/10.1186/s13223-020-00439-9
_version_ 1783539577230721024
author Farkas, Henriette
Levy, Donald
Supina, Dylan
Berger, Melvin
Prusty, Subhransu
Fridman, Moshe
author_facet Farkas, Henriette
Levy, Donald
Supina, Dylan
Berger, Melvin
Prusty, Subhransu
Fridman, Moshe
author_sort Farkas, Henriette
collection PubMed
description In this letter to the editor, we present results of claims data analysis. This claims data analysis supports a hypothesis that in patients with hereditary angioedema due to C1-esterase inhibitor (C1-INH) deficiency, the occurrence and/or symptomatology of coexisting autoimmune disease may be positively influenced by a replacement therapy with plasma derived C1-INH.
format Online
Article
Text
id pubmed-7254637
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72546372020-06-07 Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database Farkas, Henriette Levy, Donald Supina, Dylan Berger, Melvin Prusty, Subhransu Fridman, Moshe Allergy Asthma Clin Immunol Letter to the Editor In this letter to the editor, we present results of claims data analysis. This claims data analysis supports a hypothesis that in patients with hereditary angioedema due to C1-esterase inhibitor (C1-INH) deficiency, the occurrence and/or symptomatology of coexisting autoimmune disease may be positively influenced by a replacement therapy with plasma derived C1-INH. BioMed Central 2020-05-27 /pmc/articles/PMC7254637/ /pubmed/32514273 http://dx.doi.org/10.1186/s13223-020-00439-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Farkas, Henriette
Levy, Donald
Supina, Dylan
Berger, Melvin
Prusty, Subhransu
Fridman, Moshe
Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
title Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
title_full Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
title_fullStr Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
title_full_unstemmed Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
title_short Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
title_sort hereditary angioedema c1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254637/
https://www.ncbi.nlm.nih.gov/pubmed/32514273
http://dx.doi.org/10.1186/s13223-020-00439-9
work_keys_str_mv AT farkashenriette hereditaryangioedemac1esteraseinhibitorreplacementtherapyandcoexistingautoimmunedisordersfindingsfromaclaimsdatabase
AT levydonald hereditaryangioedemac1esteraseinhibitorreplacementtherapyandcoexistingautoimmunedisordersfindingsfromaclaimsdatabase
AT supinadylan hereditaryangioedemac1esteraseinhibitorreplacementtherapyandcoexistingautoimmunedisordersfindingsfromaclaimsdatabase
AT bergermelvin hereditaryangioedemac1esteraseinhibitorreplacementtherapyandcoexistingautoimmunedisordersfindingsfromaclaimsdatabase
AT prustysubhransu hereditaryangioedemac1esteraseinhibitorreplacementtherapyandcoexistingautoimmunedisordersfindingsfromaclaimsdatabase
AT fridmanmoshe hereditaryangioedemac1esteraseinhibitorreplacementtherapyandcoexistingautoimmunedisordersfindingsfromaclaimsdatabase

Ejemplares similares